INS and type 2 diabetes mellitus: It has been suggested that the insufficient inhibition of protein breakdown, attributable to insulin insensitivity and dysfunctional BCAA catabolism, might explain higher concentrations of these amino acids in T2DM (Vanweert et al., 2022).